Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
基本信息
- 批准号:10259745
- 负责人:
- 金额:$ 45.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityAddressAdministratorAffectAmericanBenchmarkingCaringClinicalContractsCost ControlDataDropsEnd stage renal failureEvaluationFee-for-Service PlansHealthHealth Care CostsHealthcareHospitalsIncentivesInformation SystemsInterviewLocationMeasuresMedicareMedicare claimModelingMotivationOrganizational ModelsOutcomePathway interactionsPatient SelectionPatientsPerformancePhysiciansPopulationPreventive servicePriceProcessProviderQuality of CareRewardsRiskSamplingSavingsStandardizationStructureTelephoneUnited States Centers for Medicare and Medicaid ServicesWorkbasebeneficiarycare coordinationcare costscare deliverycostcost shiftingfallsfinancial incentivehealth care qualityhealth managementhigh riskimprovedinnovationinsightmindfulnessnext generationolder patientoptimismpaymentpopulation healthprogramssuccess
项目摘要
PROJECT SUMMARY
Older patients receive fragmented healthcare that is of variable quality and cost. To address this problem, the
Centers for Medicare & Medicaid Services (CMS) developed accountable care organizations (ACOs). ACOs
create incentives for providers to work together, while being mindful of their spending. Evaluations of the
Medicare Shared Savings Program (MSSP)—CMS’s largest ACO initiative—show that participating
organizations have improved care quality for older patients. Nonetheless, their costs remain high because they
do not have enough “skin in the game.” The majority of ACOs have contracts in which they share a small
percentage of the savings with Medicare when they reduce their annual costs below a benchmark but are not
penalized if they fall short (i.e., they have no downside risk). Without the financial threat of downside risk,
ACOs have less reason to innovate and increase efficiency. Thus, CMS announced “Pathways to Success” in
December 2018, requiring current MSSP ACOs to shift to downside risk in as little as one year. However,
shifting so quickly may be detrimental. The MSSP is voluntary, and many ACOs that have engaged in
meaningful care redesign may not be ready to take on the possibility of having to repay CMS millions and
leave the program instead. Indeed, 40% of ACOs facing contract renewal this July dropped out. Without the
potential for shared savings, exiting ACOs may divest their data systems and coordination capabilities needed
for population health management, which are costly to maintain. In turn, the ACOs’ patients may suffer lower
care quality and higher costs. The decision to stay in the MSSP may have unintended consequences, too.
ACOs may pursue cost-containment strategies like favorable patient selection. They may also limit their focus
to CMS-required metrics (at the expense of other clinically important ones). These moves would hurt older
patients who stand to gain the most from ACOs. In this context, we propose a combined qualitative and
quantitative study with three Specific Aims. 1) To examine decisions around MSSP participation and the
impact that these decisions have on an organization’s approach to care delivery after launch of
Pathways to Success. Using administrative data, we will purposefully sample 12 ACOs without downside risk
that faced contract renewal in 2019—six that renewed and six that did not. We will conduct semi-structured
phone interviews with key stakeholders to better understand what factors influenced their participation decision
and how their decision is affecting their efforts to improve care coordination and population health. 2) To
assess the effects of MSSP exit on clinical quality and costs among older patients. We will analyze
national Medicare claims (2008 to 2022) and identify MSSP-aligned fee-for-service beneficiaries. Among these
beneficiaries, we will then measure their healthcare quality and costs (based on CMS-required outcome and
process metrics and total price-standardized Medicare spending) before and after launch of Pathways to
Success. 3) To evaluate for unintended consequences on older patients from continued participation.
For ACOs identified in Aim 2 that remain in the MSSP, we will evaluate whether they take part in favorable
patient selection. We will also measure their organizational performance against CMS-required and non-
required outcome and process metrics before and after launch of Pathways to Success. Impact. Findings from
our study will provide policymakers with actionable insights as they incorporate downside risk into advanced
payment models and serve to inform ACO stakeholders who are considering organizational next steps.
项目总结
老年患者得到的医疗保健支离破碎,质量和成本各不相同。为了解决这个问题,
医疗保险和医疗补助服务中心(CMS)发展了负责任的护理组织(ACO)。ACOS
创造激励措施,鼓励供应商合作,同时注意他们的支出。对该计划的评价
联邦医疗保险共享储蓄计划(MSSP)-CMS最大的ACO计划-表明参与
各组织已经提高了对老年患者的护理质量。然而,他们的成本仍然很高,因为他们
在游戏中没有足够的“皮囊”。大多数ACO都有合同,在合同中他们共享一小部分
当他们将年度成本降低到基准以下但未降低时,联邦医疗保险节省的百分比
如果它们达不到要求(即它们没有下行风险),就会受到惩罚。如果没有下行风险的金融威胁,
ACO没有太多理由去创新和提高效率。因此,CMS在#年宣布了“成功之路”。
2018年12月,要求目前的MSSP ACO在短短一年内转变为下行风险。然而,
转变得如此之快可能是有害的。MSSP是自愿的,许多ACO参与了
有意义的护理重新设计可能还没有准备好承担不得不偿还CMS数百万美元和
取而代之的是退出程序。事实上,今年7月面临续约的ACO中有40%退出了。如果没有
共享节省的潜力,退出的ACO可能会剥离他们所需的数据系统和协调能力
用于人口健康管理,维护成本高昂。反过来,ACOS的患者可能会遭受更低的痛苦
护理质量和更高的成本。留在MSSP的决定可能也会产生意想不到的后果。
ACO可能会采取成本控制策略,如有利的患者选择。他们也可能会限制他们的关注点
到CMS所需的指标(以其他临床重要指标为代价)。这些举动会伤害年纪较大的人
从ACOS中获益最多的患者。在这一背景下,我们提出了定性和定量相结合的
有三个具体目标的定量研究。1)审查有关MSSP参与的决策和
这些决定对组织在推出后提供护理服务的方法产生的影响
通向成功的道路。使用管理数据,我们将有目的地抽样12个没有下行风险的ACO
该公司在2019年面临续签合同--6家续签了合同,6家没有续签。我们将进行半结构化
与主要利益相关者进行电话采访,以更好地了解哪些因素影响他们的参与决策
以及他们的决定如何影响他们改善护理协调和人口健康的努力。2)至
评估MSSP退出对老年患者临床质量和成本的影响。我们将分析
国家医疗保险索赔(2008至2022年),并确定与MSSP一致的按服务收费受益人。其中包括
受益人,然后我们将衡量他们的医疗质量和成本(基于CMS所需的结果和
流程指标和总价格-标准化医疗保险支出)在启动路径之前和之后
成功。3)评估继续参与对老年患者的意外后果。
对于在目标2中确定的仍留在MSSP中的ACO,我们将评估他们是否参与了有利的
病人选择。我们还将对照CMS-Required和Non-CMS衡量他们的组织绩效
《通向成功之路》发布前后所需的结果和流程指标。冲击力。调查结果来自
我们的研究将为政策制定者提供可操作的见解,因为他们将下行风险纳入
支付模式,并用于通知正在考虑组织下一步行动的ACO利益相关者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Malcolm Hollingsworth其他文献
John Malcolm Hollingsworth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Malcolm Hollingsworth', 18)}}的其他基金
Real-world effectiveness of preventive pharmacological therapy for patients with kidney stones
肾结石患者预防性药物治疗的真实有效性
- 批准号:
10372926 - 财政年份:2020
- 资助金额:
$ 45.51万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10026743 - 财政年份:2020
- 资助金额:
$ 45.51万 - 项目类别:
Real-world effectiveness of preventive pharmacological therapy for patients with kidney stones
肾结石患者预防性药物治疗的真实有效性
- 批准号:
10584488 - 财政年份:2020
- 资助金额:
$ 45.51万 - 项目类别:
Assessing the Effects of Accountable Care Organizations on Surgical Spending and Quality
评估负责任的医疗组织对手术支出和质量的影响
- 批准号:
9788224 - 财政年份:2016
- 资助金额:
$ 45.51万 - 项目类别:
Assessing the Effects of Accountable Care Organizations on Surgical Spending and Quality
评估负责任的医疗组织对手术支出和质量的影响
- 批准号:
9237741 - 财政年份:2016
- 资助金额:
$ 45.51万 - 项目类别:
Will the Reach of ACOs Extend to Specialty Care?
ACO 的覆盖范围是否会扩展到特殊护理?
- 批准号:
9916669 - 财政年份:2016
- 资助金额:
$ 45.51万 - 项目类别:
Effects of Physician Social Networks on Surgical Quality, Safety, and Costs
医生社交网络对手术质量、安全性和成本的影响
- 批准号:
8382949 - 财政年份:2012
- 资助金额:
$ 45.51万 - 项目类别:
Effects of Physician Social Networks on Surgical Quality, Safety, and Costs
医生社交网络对手术质量、安全性和成本的影响
- 批准号:
8730124 - 财政年份:2012
- 资助金额:
$ 45.51万 - 项目类别:
Effects of Physician Social Networks on Surgical Quality, Safety, and Costs
医生社交网络对手术质量、安全性和成本的影响
- 批准号:
8549162 - 财政年份:2012
- 资助金额:
$ 45.51万 - 项目类别:
Effects of Physician Social Networks on Surgical Quality, Safety, and Costs
医生社交网络对手术质量、安全性和成本的影响
- 批准号:
8919962 - 财政年份:2012
- 资助金额:
$ 45.51万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 45.51万 - 项目类别:
Research Grant














{{item.name}}会员




